Thought Leadership

It seems as if the conversation around the nature of healthcare’s AI future is one that’s been conducted without the voices of patients themselves

With the explosion of interest in patient centricity, it made strategic good sense to develop SO Patient, a joint venture between Havas SO and Redmond Consulting co-led by patient engagement ‘guru’ Kathy Redmond and health PR expert Moira Gitsham

This white paper will demonstrate that an investment in an instrument data system including validation can bring substantial business benefits to both a laboratory and its parent organisation

Medical Affairs professionals have a critical role to play – however, historically, it has been difficult for them to gain consistent access to critical data and analytics

Digitally-augmented multi-channel engagement has proved to be a useful approach for working with patients. However, it is easy for  developers to default to a patient-facing website or an app that looks good and sounds impressive, but in practice doesn’t supply what patients want and need

PharmaMar is one of the few biopharmaceutical companies to have a product on the market, another awaiting commercialisation and various more at different stages of clinical development

The model that sees information flow linearly, from pharmaceutical companies, to healthcare professionals, or patient groups and patients, is outmoded and doesn’t work well for any of the parties involved.

Building better relationships based on partnership and collaboration creates more effective outcomes

Business development director at Star, Ryan Wooller, discusses commercial outsourcing and how the company has adapted to provide the best solutions as pharma companies look to innovate and reduce costs

Biologic drugs are big. A heterogeneous mixture of more than 1,300 weighty amino acids, they are hundreds of times the 1- to 2 ml size of conventional small molecule injectables. That renders them hard to make – and even harder for patients to take.

Jeff Zucker of Worldwide Clinical Trials explains the key to improving study site performance

When we ignore carers, we miss out on one of our best shots at driving treatment success, says David Hunt, CEO of Havas Lynx